Clinical trial
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM)…
NCT00100087 · Theragenics Corporation, Industry · Unknown status
Key facts
| NCT number | NCT00100087 |
|---|---|
| Title | Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System |
| Official title | A Safety and Feasibility Study of the TheraSight(TM) Ocular Brachytherapy System for Treatment of Age-Related Macular Degeneration |
| Lead sponsor | Theragenics Corporation, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Macular Degeneration, Choroidal Neovascularization |
| Intervention type | Device |
| Interventions | Ocular Brachytherapy |
| Enrollment | 30 |
| Start date | Oct 1, 2004 |
| First posted | Dec 23, 2004 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: